Pudendal Neuralgia: A New Option for Treatment? Preliminary Results on Feasibility and Efficacy

Marco Venturi, Paolo Boccasanta, Bruno Lombardi, Max Brambilla, Ettore Contessini Avesani, Contardo Vergani

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: The aim of this prospective study was to investigate the feasibility and report the short-term results of a new procedure for treatment of pudendal neuralgia, consisting of transperineal injections of autologous adipose tissue with stem cells along the Alcock's canal. Methods: Fifteen women with pudendal neuralgia not responsive to 3-months medical therapy were examined clinically, with VAS score, validated SF-36 questionnaire, and pudendal nerve motor terminal latency (PNMTL). These patients were submitted to pudendal nerve lipofilling. Clinical examinations with VAS, SF36, and PNTML were scheduled during 12 months follow-up, with the incidence of pain recurrence (VAS > 5) as primary outcome measure. Appropriate tests were used for statistics. Results: All patients had preoperative increase of pudendal nerve latencies. Twelve patients completed the follow-up protocol. There was no mortality, and no complications. Two patients had no pain improvement and continued to use analgesic drugs. At 12 months VAS significantly improved (3.2±0.6 vs 8.1±0.9, P

Original languageEnglish
Pages (from-to)1475-1481
Number of pages7
JournalPain Medicine (United States)
Volume16
Issue number8
DOIs
Publication statusPublished - Aug 1 2015

Fingerprint

Pudendal Neuralgia
Pudendal Nerve
Pain
Therapeutics
Analgesics
Adipose Tissue
Stem Cells
Outcome Assessment (Health Care)
Prospective Studies
Recurrence
Injections
Mortality
Incidence

Keywords

  • Lipofilling
  • Pudendal Neuralgia
  • Stem Cells

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Pudendal Neuralgia : A New Option for Treatment? Preliminary Results on Feasibility and Efficacy. / Venturi, Marco; Boccasanta, Paolo; Lombardi, Bruno; Brambilla, Max; Contessini Avesani, Ettore; Vergani, Contardo.

In: Pain Medicine (United States), Vol. 16, No. 8, 01.08.2015, p. 1475-1481.

Research output: Contribution to journalArticle

Venturi, M, Boccasanta, P, Lombardi, B, Brambilla, M, Contessini Avesani, E & Vergani, C 2015, 'Pudendal Neuralgia: A New Option for Treatment? Preliminary Results on Feasibility and Efficacy', Pain Medicine (United States), vol. 16, no. 8, pp. 1475-1481. https://doi.org/10.1111/pme.12693
Venturi, Marco ; Boccasanta, Paolo ; Lombardi, Bruno ; Brambilla, Max ; Contessini Avesani, Ettore ; Vergani, Contardo. / Pudendal Neuralgia : A New Option for Treatment? Preliminary Results on Feasibility and Efficacy. In: Pain Medicine (United States). 2015 ; Vol. 16, No. 8. pp. 1475-1481.
@article{7cf548d200da479086c278abc57b4b06,
title = "Pudendal Neuralgia: A New Option for Treatment? Preliminary Results on Feasibility and Efficacy",
abstract = "Objective: The aim of this prospective study was to investigate the feasibility and report the short-term results of a new procedure for treatment of pudendal neuralgia, consisting of transperineal injections of autologous adipose tissue with stem cells along the Alcock's canal. Methods: Fifteen women with pudendal neuralgia not responsive to 3-months medical therapy were examined clinically, with VAS score, validated SF-36 questionnaire, and pudendal nerve motor terminal latency (PNMTL). These patients were submitted to pudendal nerve lipofilling. Clinical examinations with VAS, SF36, and PNTML were scheduled during 12 months follow-up, with the incidence of pain recurrence (VAS > 5) as primary outcome measure. Appropriate tests were used for statistics. Results: All patients had preoperative increase of pudendal nerve latencies. Twelve patients completed the follow-up protocol. There was no mortality, and no complications. Two patients had no pain improvement and continued to use analgesic drugs. At 12 months VAS significantly improved (3.2±0.6 vs 8.1±0.9, P",
keywords = "Lipofilling, Pudendal Neuralgia, Stem Cells",
author = "Marco Venturi and Paolo Boccasanta and Bruno Lombardi and Max Brambilla and {Contessini Avesani}, Ettore and Contardo Vergani",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/pme.12693",
language = "English",
volume = "16",
pages = "1475--1481",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Pudendal Neuralgia

T2 - A New Option for Treatment? Preliminary Results on Feasibility and Efficacy

AU - Venturi, Marco

AU - Boccasanta, Paolo

AU - Lombardi, Bruno

AU - Brambilla, Max

AU - Contessini Avesani, Ettore

AU - Vergani, Contardo

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective: The aim of this prospective study was to investigate the feasibility and report the short-term results of a new procedure for treatment of pudendal neuralgia, consisting of transperineal injections of autologous adipose tissue with stem cells along the Alcock's canal. Methods: Fifteen women with pudendal neuralgia not responsive to 3-months medical therapy were examined clinically, with VAS score, validated SF-36 questionnaire, and pudendal nerve motor terminal latency (PNMTL). These patients were submitted to pudendal nerve lipofilling. Clinical examinations with VAS, SF36, and PNTML were scheduled during 12 months follow-up, with the incidence of pain recurrence (VAS > 5) as primary outcome measure. Appropriate tests were used for statistics. Results: All patients had preoperative increase of pudendal nerve latencies. Twelve patients completed the follow-up protocol. There was no mortality, and no complications. Two patients had no pain improvement and continued to use analgesic drugs. At 12 months VAS significantly improved (3.2±0.6 vs 8.1±0.9, P

AB - Objective: The aim of this prospective study was to investigate the feasibility and report the short-term results of a new procedure for treatment of pudendal neuralgia, consisting of transperineal injections of autologous adipose tissue with stem cells along the Alcock's canal. Methods: Fifteen women with pudendal neuralgia not responsive to 3-months medical therapy were examined clinically, with VAS score, validated SF-36 questionnaire, and pudendal nerve motor terminal latency (PNMTL). These patients were submitted to pudendal nerve lipofilling. Clinical examinations with VAS, SF36, and PNTML were scheduled during 12 months follow-up, with the incidence of pain recurrence (VAS > 5) as primary outcome measure. Appropriate tests were used for statistics. Results: All patients had preoperative increase of pudendal nerve latencies. Twelve patients completed the follow-up protocol. There was no mortality, and no complications. Two patients had no pain improvement and continued to use analgesic drugs. At 12 months VAS significantly improved (3.2±0.6 vs 8.1±0.9, P

KW - Lipofilling

KW - Pudendal Neuralgia

KW - Stem Cells

UR - http://www.scopus.com/inward/record.url?scp=84939563629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939563629&partnerID=8YFLogxK

U2 - 10.1111/pme.12693

DO - 10.1111/pme.12693

M3 - Article

C2 - 25677417

AN - SCOPUS:84939563629

VL - 16

SP - 1475

EP - 1481

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 8

ER -